Elsevier

Experimental Cell Research

Volume 313, Issue 20, 10 December 2007, Pages 4120-4129
Experimental Cell Research

Research Article
Microcytosis in ank/ank mice and the role of ANKH in promoting erythroid differentiation

https://doi.org/10.1016/j.yexcr.2007.09.008Get rights and content

Abstract

Progressive ankylosis (Ank and the human homolog, ANKH) is a transmembrane protein which regulates transport of inorganic pyrophosphate (PPi). ank/ank mice with a mutated ank gene, have calcification and bone ankylosis of the affected joints. In the course of studying these mutant mice, we found that they have microcytosis. These mutant mice have lower mean red blood cell volume (MCV) and lower hemoglobin content in red cells (mean corpuscular hemoglobin, MCH) than normal mice. Using quantitative real-time PCR analysis, we showed that Ank was expressed in the E/Meg bipotent precursor, BFU-E, CFU-E, but there was no Ank expression in the hemoglobinizing erythroblasts. Stable ANKH transfectants in K562 cells highly expressed two immature erythroid cell markers, E-cadherin and endoglin. Enhanced Erythropoietin (Epo) expression and downregulation of SHP-1 were detected in these transfectants. Consequently, the autocrine Epo–EpoR signaling pathway was activated, as evidenced by higher p-Tyr JAK2, p-Tyr EpoR and p-Tyr STAT5B in the ANKH transfectants. Our results revealed a novel function of ANKH in the promotion of early erythroid differentiation in K562 cells. We also showed that ank/ank mice have lower serum levels of Epo than the normal littermates, and this is the likely cause of microcytosis in these mutant mice.

Introduction

The mutated gene, ank, of the spontaneous mutant mice progressive ankylosis, was first identified in 2000, and is a nonsense mutation in the exon 11 of the Ank gene [1]. Although the gene product is quite ubiquitously expressed, the only significant phenotype found in the homozygous mutant mice is characterized by pathologic calcium apatite crystal deposition in the synovial and subsynovial spaces followed by chondro-osteophyte formation and eventual bony ankylosis of the affected joint. There was also a report on defective splenic T cell mitogenic response to PHA and ConA in these mutant mice [2]. Heterozygous ank mice have a normal phenotype, but loss of the Ank function in homozygous ank mice causes increased intracellular [PPi] (i[PPi]), and decreased extracellular [PPi] (e[PPi]) levels [1]. Recently, an Ank null mouse was generated and the phenotype of the homozygous Ank null mice was indistinguishable from that of ank/ank mice [3]. Furthermore, mice with joint-specific deletion of Ank alleles also showed joint mineralization and ankylosis, indicating that Ank function is required locally in joints to prevent mineral formation and ensure joint mobility and function [3].

The Ank protein is a multipass transmembrane protein which regulates PPi export from the intracellular to the extracellular compartments. The human ANKH protein is very similar to the mouse Ank protein, differing by nine of the entire 492 amino acids. Both Ank and NPP-1 were required to elevate e[PPi] constitutively and following TGFβ induction [4], suggesting that Ank may facilitate export of NTP, a substrate for NPP-1 on the outer cell membrane. A decrease in intracellular NTP would reduce the available intracellular NTP for intracellular hydrolysis to [PPi], lowering i[PPi] and e[PPi] levels. In humans, autosomal dominant craniometaphyseal dysplasia (CMD) is caused by ANKH mutations [5], [6]. Heterozygous ANKH mutations were detected in at least five multiplex families with chondrocalcinosis (calcium pyrophosphate dihydrate deposition disease) [7], [8], [9], [10], [11]. It remains unclear how these mutations lead to pathogenesis of the disease, though they appear to be dominant negative mutations in CMD and gain-of-function mutations in chondrocalcinosis [12].

The observation that Ank is a polypeptide growth factor-, serum- and tumor promoter-inducible gene in fibroblasts led to the proposal that in cells with high metabolic activity, Ank is required for efficient removal of excess i[PPi] generated by consumption of ATP [13]. The notion that Ank/ANKH might have function(s) additional to that of exporting PPi is not new. Upregulation of MMP13 expression was induced by over-expression of Ank in primary bovine chondrocytes [4]. In the course of studying the ank/ank mice, we found that they have microcytosis. In this study, we specifically asked whether Ank/ANKH play a role in erythropoiesis. We examined Ank expression in various differentiation stages of erythropoiesis. As redundancy of proteins with similar functions might complicate the identification of some tissue-specific function(s) of Ank in the ank/ank mutant mice, instead of performing in vitro knock down of Ank/ANKH in culture cells, we used the approach of over-expressing ANKH in specific cell types which might enable the detection of novel ANKH function(s). K562 cells were derived from a patient with chronic myeloid leukemia (CML) in terminal blast crisis [14], and were commonly used as a model for erythroid differentiation as these leukemic cells can be induced to undergo erythroid differentiation by various agents such as hemin, butyrate, cisplatin and ara-C [15], [16]. Here we report the generation of stable ANKH transfectants in K562 cells, and show that ANKH promotes early erythroid differentiation.

Section snippets

Breeding and maintenance of ank/ank mice

A breeding pair of ank/+ mice (C3FeB6-A/Aw-jank+/−) was obtained from the Jackson Laboratory (Bar Harbor, ME) and a breeding colony was maintained in the animal facility, Toronto Western Research Institute. ank/ank mice were initially generated by crossbreeding heterozygous offspring of the breeding pairs. Later, heterozyotes from larger litters were used as breeders, as in general, they give more mutant mice. Mice were genotyped using tail DNA as described by Ho et al. [1]. We arbitrarily

ank/ank mice have microcytosis

Blood was obtained from ank/ank and wild-type littermates (12 for each group) and erythrocyte indices are summarized in Table 2. There were no age and gender differences in these parameters with each group (mutant vs. wild-type mice). Compared to normal littermates, the mutant mice had significantly lower mean corpuscular volume (MCV; 50.6 ± 0.59 [normal] vs. 43.9 ± 0.39 [mutant]; p-value < 0.001) and mean corpuscular hemoglobin (MCH [pg/RBC]; 16.0 ± 0.64 [normal] vs. 13.6 ± 0.15 [mutant]; p-value = 0.002)

Discussion

In this study, we showed that ank/ank mice which have a loss of Ank function develop red cell microcytosis. Inflammation is a potential factor which might influence red cell size and number [31]. In the literature, both the presence of joint inflammation [32], [33] and the lack of evidence of inflammation in the joints of ank/ank mice [34] were reported. In our colony of ank/ank mice, we observed synovial proliferation, increase of calcified matrix, joint narrowing and small calcific deposits (

Acknowledgments

Supported by grants from the Canadian Institutes of Health Research, and the Arthritis Center of Excellence.

We wish to thank Dr. JA Winkles (American Red Cross) for his gift of anti-Ank antibodies, and Dr. R. Reithmeier (University of Toronto) for helpful discussions on the RBC proteome.

We also thank Gordana Kuruzar for the technical help in the collection of blood samples from the mice.

References (40)

  • E.M. Pasini et al.

    In-depth analysis of the membrane and cytosolic proteome of red blood cells

    Blood

    (2006)
  • B. Galy et al.

    Altered body iron distribution and microcytosis in mice deficient in iron regulatory protein 2 (IRP2)

    Blood

    (2005)
  • A. Sasaki et al.

    CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2

    J. Biol. Chem.

    (2000)
  • A.M. Ho et al.

    Role of the mouse ank gene in control of tissue calcification and arthritis

    Science

    (2000)
  • H.E. Krug et al.

    Progressive ankylosis (ank/ank) in mice: an animal model of spondyloarthropathy: III. Proliferative spleen cell response to T cell mitogens

    Clin. Exp. Immunol.

    (1989)
  • K.A. Gurley et al.

    Mineral formation in joints caused by complete or joint-specific loss of ANK function

    J. Bone Miner. Res.

    (2006)
  • K. Johnson et al.

    Upregulated ank expression in osteoarthritis can promote both chondrocyte MMP-13 expression and calcification via chondrocyte extracellular PPi excess

    OsteoArthr. Cartil.

    (2004)
  • P. Nurnberg et al.

    Heterozygous mutations in ANKH, the human ortholog of the mouse progressive ankylosis gene, result in craniometaphyseal dysplasia

    Nat. Genet.

    (2001)
  • C.J. Williams et al.

    Mutations in the amino terminus of ANKH in two US families with calcium pyrophosphate dihydrate crystal deposition disease

    Arthritis Rheum.

    (2003)
  • Y. Zhang et al.

    Association of sporadic chondrocalcinosis with a 4-basepair G-to-A transition in the 5′-untranslated region of ANKH that promotes enhanced expression of ANKH protein and excess generation of extracellular inorganic pyrophosphate

    Arthritis Rheum.

    (2005)
  • Cited by (10)

    View all citing articles on Scopus
    View full text